KR960703592A - 정신병 치료방법(Antipsychotic method) - Google Patents

정신병 치료방법(Antipsychotic method)

Info

Publication number: KR960703592A
Authority: KR; South Korea
Prior art keywords: mammal; antipsychotic method; antipsychotic; schizophrenia; sulphur
Prior art date: 1993-08-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

KR1019960700806A

Other languages

English (en)

Other versions

KR100360575B1 (ko

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-08-19

Filing date

1996-02-16

Publication date

1996-08-31

1994-08-15 Application filed filed Critical

1996-08-31 Publication of KR960703592A publication Critical patent/KR960703592A/ko

2003-03-10 Application granted granted Critical

2003-03-10 Publication of KR100360575B1 publication Critical patent/KR100360575B1/ko

2014-08-15 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

KR1019960700806A 1993-08-19 1994-08-15 정신분열증및정신분열형질환치료용약제학적조성물 Expired - Fee Related KR100360575B1 (ko)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10930093A	1993-08-19	1993-08-19
US08/109300		1993-08-19

Publications (2)

Publication Number	Publication Date
KR960703592A true KR960703592A (ko)	1996-08-31
KR100360575B1 KR100360575B1 (ko)	2003-03-10

Family

ID=22326932

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1019960700806A Expired - Fee Related KR100360575B1 (ko)	1993-08-19	1994-08-15	정신분열증및정신분열형질환치료용약제학적조성물

Country Status (23)

Country	Link
EP (1)	EP0734259B1 (ko)
JP (1)	JP3126736B2 (ko)
KR (1)	KR100360575B1 (ko)
CN (1)	CN1087936C (ko)
AT (1)	ATE218864T1 (ko)
AU (1)	AU701292B2 (ko)
CA (1)	CA2169839C (ko)
CZ (1)	CZ285030B6 (ko)
DE (1)	DE69430816T2 (ko)
DK (1)	DK0734259T3 (ko)
ES (1)	ES2177581T3 (ko)
FI (2)	FI960747L (ko)
HU (1)	HU221729B1 (ko)
IL (1)	IL110708A (ko)
NO (1)	NO312706B1 (ko)
NZ (2)	NZ336597A (ko)
PT (1)	PT734259E (ko)
RU (1)	RU2191580C2 (ko)
SG (1)	SG55071A1 (ko)
TW (1)	TW442284B (ko)
UA (1)	UA63876C2 (ko)
WO (1)	WO1995005174A1 (ko)
ZA (1)	ZA946324B (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5821371A (en) *	1994-10-24	1998-10-13	Eli Lilly And Comany	Heterocyclic compounds and their preparation and use
US5605908A (en) *	1994-10-24	1997-02-25	Eli Lilly And Company	Heterocyclic compounds and their use
US5998404A (en) *	1994-10-24	1999-12-07	Eli Lilly And Company	Heterocyclic compounds and their use
US5726193A (en) *	1994-10-31	1998-03-10	Eli Lilly And Company	Method for treating anxiety
AU4139096A (en) *	1994-10-31	1996-05-23	Eli Lilly And Company	Method for treating anxiety
US5574028A (en) *	1994-10-31	1996-11-12	Eli Lilly And Company	Method for treating anxiety
US5488056A (en) *	1994-10-31	1996-01-30	Eli Lilly And Company	Method for treating anxiety
US5565475A (en) *	1994-11-08	1996-10-15	Muhlhauser; Mark A.	Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
US5763457A (en) *	1995-11-13	1998-06-09	Eli Lilly And Company	Method for treating anxiety
US5852037A (en) *	1995-11-13	1998-12-22	Eli Lilly And Company	Method for treating anxiety
EP0821956A1 (en) *	1996-08-01	1998-02-04	Eli Lilly And Company	Method for treating disruptive behavior disorders
EP0821959A3 (en) *	1996-08-01	1998-09-16	Eli Lilly And Company	Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine for treating nicotine withdrawal
EP0821954A1 (en) *	1996-08-01	1998-02-04	Eli Lilly And Company	Method for treating mental retardation
EP0821957A3 (en) *	1996-08-01	1998-04-22	Eli Lilly And Company	Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse
US6090829A (en) *	1996-08-01	2000-07-18	Eli Lilly And Company	Method for treating excessive aggression
EP0821958A3 (en) *	1996-08-01	1998-07-08	Eli Lilly And Company	Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating excessive aggression
EP0821955B1 (en) *	1996-08-01	2002-02-20	Eli Lilly And Company	Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating bipolar disorder
US6043258A (en) *	1996-08-01	2000-03-28	Eli Lilly And Company	Method for treating disruptive behavior disorders with xanomeline
US6117890A (en) *	1996-08-01	2000-09-12	Eli Lilly And Company	Method for treating bipolar disorder
EP1014974B1 (en)	1997-05-29	2004-08-11	H. Lundbeck A/S	Treatment of schizophrenia and psychosis
US6034108A (en) *	1997-07-28	2000-03-07	Eli Lilly And Company	Method for treating mental retardation
WO2011011060A1 (en)	2009-07-22	2011-01-27	Puretech Ventures	Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
SG11202102349PA (en) *	2018-09-28	2021-04-29	Karuna Therapeutics Inc	Compositions and methods for treating disorders ameliorated by muscarnic receptor activation
WO2021097427A1 (en)	2019-11-15	2021-05-20	Karuna Therapeutics, Inc.	Xanomeline derivatives and methods for treating neurological disorders
WO2023061372A1 (zh) *	2021-10-14	2023-04-20	南京迈诺威医药科技有限公司	占诺美林衍生物的苹果酸盐、a晶型及其制备方法和用途
CN119161338B (zh) *	2024-11-25	2025-06-17	嘉兴安帝康生物科技有限公司	用作毒蕈碱受体激动剂的四氢吡啶衍生物及其在医药上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ225999A (en) *	1987-09-10	1992-04-28	Merck Sharp & Dohme	Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
US5043345A (en) *	1989-02-22	1991-08-27	Novo Nordisk A/S	Piperidine compounds and their preparation and use
DK198390D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198490D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse

1994
- 1994-08-15 AU AU74902/94A patent/AU701292B2/en not_active Ceased
- 1994-08-15 WO PCT/DK1994/000305 patent/WO1995005174A1/en active Application Filing
- 1994-08-15 CZ CZ96426A patent/CZ285030B6/cs not_active IP Right Cessation
- 1994-08-15 CN CN94193733A patent/CN1087936C/zh not_active Expired - Fee Related
- 1994-08-15 DE DE69430816T patent/DE69430816T2/de not_active Expired - Lifetime
- 1994-08-15 SG SG1996004738A patent/SG55071A1/en unknown
- 1994-08-15 NZ NZ336597A patent/NZ336597A/en unknown
- 1994-08-15 ES ES94924708T patent/ES2177581T3/es not_active Expired - Lifetime
- 1994-08-15 FI FI960747A patent/FI960747L/fi not_active Application Discontinuation
- 1994-08-15 HU HU9600364A patent/HU221729B1/hu not_active IP Right Cessation
- 1994-08-15 KR KR1019960700806A patent/KR100360575B1/ko not_active Expired - Fee Related
- 1994-08-15 PT PT94924708T patent/PT734259E/pt unknown
- 1994-08-15 JP JP07506691A patent/JP3126736B2/ja not_active Expired - Lifetime
- 1994-08-15 RU RU96105388/14A patent/RU2191580C2/ru not_active IP Right Cessation
- 1994-08-15 NZ NZ271311A patent/NZ271311A/en not_active IP Right Cessation
- 1994-08-15 CA CA002169839A patent/CA2169839C/en not_active Expired - Fee Related
- 1994-08-15 EP EP94924708A patent/EP0734259B1/en not_active Expired - Lifetime
- 1994-08-15 AT AT94924708T patent/ATE218864T1/de not_active IP Right Cessation
- 1994-08-15 DK DK94924708T patent/DK0734259T3/da active
- 1994-08-15 UA UA96020584A patent/UA63876C2/uk unknown
- 1994-08-18 IL IL11070894A patent/IL110708A/en not_active IP Right Cessation
- 1994-08-19 ZA ZA946324A patent/ZA946324B/xx unknown
1995
- 1995-02-15 TW TW084101387A patent/TW442284B/zh not_active IP Right Cessation
1996
- 1996-02-16 NO NO19960619A patent/NO312706B1/no not_active IP Right Cessation
2005
- 2005-04-29 FI FI20050461A patent/FI20050461L/fi not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL110708A0 (en)	1994-11-11
HUT75111A (en)	1997-04-28
HU9600364D0 (en)	1996-04-29
DE69430816D1 (de)	2002-07-18
SG55071A1 (en)	1998-12-21
CA2169839C (en)	2002-06-11
EP0734259B1 (en)	2002-06-12
ZA946324B (en)	1996-02-19
CA2169839A1 (en)	1995-02-23
IL110708A (en)	1998-12-06
FI960747A0 (fi)	1996-02-19
AU7490294A (en)	1995-03-14
FI960747A7 (fi)	1996-04-17
ES2177581T3 (es)	2002-12-16
AU701292B2 (en)	1999-01-21
ATE218864T1 (de)	2002-06-15
NO960619L (no)	1996-04-18
PT734259E (pt)	2002-11-29
RU2191580C2 (ru)	2002-10-27
NZ336597A (en)	2001-02-23
KR100360575B1 (ko)	2003-03-10
FI960747L (fi)	1996-04-17
UA63876C2 (en)	2004-02-16
JPH09501658A (ja)	1997-02-18
FI20050461A7 (fi)	2005-04-29
CN1087936C (zh)	2002-07-24
NO312706B1 (no)	2002-06-24
CZ42696A3 (en)	1996-11-13
CN1133008A (zh)	1996-10-09
CZ285030B6 (cs)	1999-05-12
WO1995005174A1 (en)	1995-02-23
TW442284B (en)	2001-06-23
HU221729B1 (hu)	2002-12-28
NZ271311A (en)	1999-09-29
EP0734259A1 (en)	1996-10-02
NO960619D0 (no)	1996-02-16
JP3126736B2 (ja)	2001-01-22
DK0734259T3 (da)	2002-09-30
FI20050461L (fi)	2005-04-29
DE69430816T2 (de)	2002-12-19

Publication	Publication Date	Title
DK0734259T3 (da)	2002-09-30	Antipsykotisk fremgangsmåde
EP0604641A4 (en)	1995-08-02	COMPOSITION CONTAINING AMINO DERIVATIVES OR RELATED TO BENZOIC ACID AMINES AND USES THEREOF, INCLUDING IN THE TREATMENT OF INFLAMMATORY DISEASES.
EP0613883A4 (en)	1994-12-07	HYDROXAMIC ACID DERIVATIVE.
DE69902634D1 (de)	2002-10-02	Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
FI903215A0 (fi)	1990-06-26	Heteroarylamino- och heteroaryloxipyridinaminer och till desa hoerande foereningar, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
ATE417836T1 (de)	2009-01-15	Verfahren und intermediate zur herstellung von retroviralen proteasehemmern
IL99525A0 (en)	1992-08-18	Fused ring analogs of nitrogen containing nonaromatic heterocycles
FI960748A0 (fi)	1996-02-19	Antipsykoottinen menetelmä
BR9611472A (pt)	1999-02-02	Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
ATE169217T1 (de)	1998-08-15	Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten
PT95651A (pt)	1991-09-13	Processo para a preparacao de derivados de benzo-ciclo-alquilamino-piridinaminas e de composicoes farmaceuticas que os contem
NO20003481L (no)	2000-08-25	FremgangsmÕte for behandling av COPD
DE68911237D1 (de)	1994-01-20	Nichtionische Trijodbenzin-Verbindungen und diese enthaltende Kontrastmittel.
ES2123728T3 (es)	1999-01-16	Derivados de pirrolo-pirazina de actividad 5-ht3.
ATE118209T1 (de)	1995-02-15	Pyridin-3-percarboxylsäure monopersulfat.
MX9709275A (es)	1998-03-29	Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.

Legal Events

Date	Code	Title	Description
1996-02-16	PA0105	International application	St.27 status event code: A-0-1-A10-A15-nap-PA0105
1996-02-16	R17-X000	Change to representative recorded	St.27 status event code: A-3-3-R10-R17-oth-X000
1996-08-31	PG1501	Laying open of application	St.27 status event code: A-1-1-Q10-Q12-nap-PG1501
1999-02-01	PN2301	Change of applicant	St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301
1999-02-23	R17-X000	Change to representative recorded	St.27 status event code: A-3-3-R10-R17-oth-X000
1999-08-14	A201	Request for examination
1999-08-14	P11-X000	Amendment of application requested	St.27 status event code: A-2-2-P10-P11-nap-X000
1999-08-14	P13-X000	Application amended	St.27 status event code: A-2-2-P10-P13-nap-X000
1999-08-14	PA0201	Request for examination	St.27 status event code: A-1-2-D10-D11-exm-PA0201
2000-03-02	PN2301	Change of applicant	St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301
2001-08-28	E902	Notification of reason for refusal
2001-08-28	PE0902	Notice of grounds for rejection	St.27 status event code: A-1-2-D10-D21-exm-PE0902
2001-10-26	T11-X000	Administrative time limit extension requested	St.27 status event code: U-3-3-T10-T11-oth-X000
2001-11-27	T11-X000	Administrative time limit extension requested	St.27 status event code: U-3-3-T10-T11-oth-X000
2001-12-27	T11-X000	Administrative time limit extension requested	St.27 status event code: U-3-3-T10-T11-oth-X000
2002-01-25	T11-X000	Administrative time limit extension requested	St.27 status event code: U-3-3-T10-T11-oth-X000
2002-02-27	T11-X000	Administrative time limit extension requested	St.27 status event code: U-3-3-T10-T11-oth-X000
2002-03-27	T11-X000	Administrative time limit extension requested	St.27 status event code: U-3-3-T10-T11-oth-X000
2002-04-26	P11-X000	Amendment of application requested	St.27 status event code: A-2-2-P10-P11-nap-X000
2002-04-26	P13-X000	Application amended	St.27 status event code: A-2-2-P10-P13-nap-X000
2002-08-07	E701	Decision to grant or registration of patent right
2002-08-07	PE0701	Decision of registration	St.27 status event code: A-1-2-D10-D22-exm-PE0701
2002-10-29	GRNT	Written decision to grant
2002-10-29	PR0701	Registration of establishment	St.27 status event code: A-2-4-F10-F11-exm-PR0701
2002-10-30	PR1002	Payment of registration fee	St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1
2003-03-10	PG1601	Publication of registration	St.27 status event code: A-4-4-Q10-Q13-nap-PG1601
2005-10-30	LAPS	Lapse due to unpaid annual fee
2005-10-30	PC1903	Unpaid annual fee	St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20051030 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE
2006-09-09	PC1903	Unpaid annual fee	St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20051030
2023-04-10	R18-X000	Changes to party contact information recorded	St.27 status event code: A-5-5-R10-R18-oth-X000